Reliability of the Beck Depression Inventory with older adults.

Gallagher, Dolores; Nies, Gloria; Thompson, Larry W.

doi:10.1037/0022-006x.50.1.152

Cited by 217 publications

(114 citation statements)

References 2 publications

Supporting

Mentioning

102

Contrasting

Unclassified

Order By: Relevance

“…No subjects were taking any cognitive enhancing medications or acetylcholinesterase inhibitors. Behavioral screening consisted of a partial Diagnostic Interview Schedule, 22 the Beck Depression Rating Scale, 23 and the structured Hamilton Depression Rating Scale.…”

Section: Methods Study Population One Hundred Subjectsmentioning

confidence: 99%

Nicotine treatment of mild cognitive impairment

Newhouse

Kellar²,

Aisen³

et al. 2012

Neurology

186

143

View full text Add to dashboard Cite

Objective: To preliminarily assess the safety and efficacy of transdermal nicotine therapy on cognitive performance and clinical status in subjects with mild cognitive impairment (MCI). Methods:Nonsmoking subjects with amnestic MCI were randomized to transdermal nicotine (15 mg per day or placebo) for 6 months. Primary outcome variables were attentional improvement assessed with Connors Continuous Performance Test (CPT), clinical improvement as measured by clinical global impression, and safety measures. Secondary measures included computerized cognitive testing and patient and observer ratings.Results: Of 74 subjects enrolled, 39 were randomized to nicotine and 35 to placebo. 67 subjects completed (34 nicotine, 33 placebo). The primary cognitive outcome measure (CPT) showed a significant nicotine-induced improvement. There was no statistically significant effect on clinician-rated global improvement. The secondary outcome measures showed significant nicotine-associated improvements in attention, memory, and psychomotor speed, and improvements were seen in patient/informant ratings of cognitive impairment. Safety and tolerability for transdermal nicotine were excellent. Conclusion:This study demonstrated that transdermal nicotine can be safely administered to nonsmoking subjects with MCI over 6 months with improvement in primary and secondary cognitive measures of attention, memory, and mental processing, but not in ratings of clinician-rated global impression. We conclude that this initial study provides evidence for nicotine-induced cognitive improvement in subjects with MCI; however, whether these effects are clinically important will require larger studies. Classification of evidence:This study provides Class I evidence that 6 months of transdermal nicotine (15 mg/day) improves cognitive test performance, but not clinical global impression of change, in nonsmoking subjects with amnestic MCI. Neurology ® 2012;78:91-101

show abstract

Section: Methods Study Population One Hundred Subjectsmentioning

confidence: 99%

Nicotine treatment of mild cognitive impairment

Newhouse

Kellar²,

Aisen³

et al. 2012

Neurology

186

143

View full text Add to dashboard Cite

show abstract

“…A score ≥10 suggests a depressive state [25]. High test-retest reliability (ICC = 0.90) was obtained with an elderly population [26]. …”

Section: Methodsmentioning

confidence: 99%

Changes in Participation Level after Spouse’s First Stroke and Relationship to Burden and Depressive Symptoms

et al. 2007

View full text Add to dashboard Cite

Background: No comprehensive data are available on the impact of stroke on the spouse’s participation level. The purpose of this study was to document changes in participation level over time and explore associations between changes in participation level, burden and depressive symptoms for spouses of people who had had a first stroke. Methods: Participants were spouses recruited in the first 2 weeks after admission of individuals with a first stroke to acute care. Prestroke measures (T0) were collected at recruitment, simultaneously with the first measure (T1); further measures were collected 6 months after the stroke event (T2). Participation level was measured with the LIFE-H, perceived burden with the Caregiver Strain Index and depressive symptoms using the Beck Depression Inventory (BDI). Results: Mean age of participants (n = 54) was 69 years (SD 10.9) and the majority were female (75.9%). Changes in participation include small but significant increases at T1 for the nutrition (effect size, ES, 0.34) and responsibilities (ES 0.22) domains, and large significant persistent decreases at T2 compared to T0 were found for personal relationships (ES 0.83), employment (ES 0.63) and recreation (ES 0.93). Changes in these last three participation domains are associated with a higher Caregiver Strain Index score (p < 0.01) but not with the BDI. Conclusions: Participation domains mostly affected for spouses after stroke were personal relationships, employment and recreation which could be addressed by clinicians in their provision of support.

show abstract

“…It evaluates 21 symptoms of depression that represent cognitive-affective content and somatic content. Each symptom is rated on a four-point scale (0 -3) and the scores are added to result in a total ranging from 0 to 63, with higher scores representing more severe depression (23,24). The Korean version has been validated (25).…”

Section: Beck Depression Indexmentioning

confidence: 99%

Comparison of Quality of Life Based on Surgical Technique in Patients with Breast Cancer

Young

Kim

Heo

et al. 2013

Japanese Journal of Clinical Oncology

View full text Add to dashboard Cite

Objective: More than 80% of women with breast cancer survive for more than 5 years; quality of life is an important issue in these patients. The aim of this study was to assess differences in quality of life among patients who have undergone breast-conserving surgery, total mastectomy and immediate reconstruction after total mastectomy. Methods: A cross-sectional study was conducted during follow-up visits. Women who underwent surgical treatment at least 2 years prior were eligible if they were aged 20 -70 years and had a diagnosis of breast cancer (Stages 0 -III). Quality of life was evaluated based on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire breast cancer-specific module, Rosenberg Self-esteem Scale, Beck Depression Index, Body Image Scale and sexual scale of the Cancer Rehabilitation Evaluation System. Results: A total of 407 patients completed the questionnaires; 254 were treated with breast-conserving surgery, 122 with total mastectomy and 31 with reconstruction after total mastectomy. The mean period between surgery and the survey was 49 months. Women in the breast-conserving surgery group showed better outcomes than women in the total mastectomy and reconstruction after total mastectomy groups with respect to emotional -social function, nausea/vomiting, financial difficulty, body image, arm symptoms and self-esteem. Patients in the reconstruction after total mastectomy group had significantly better outcomes on the sexual scale of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire breast cancer-specific module and arm symptoms than the total mastectomy group. Conclusions: Quality of life was better in the breast-conserving surgery group than in the total mastectomy or reconstruction after total mastectomy groups, and the total mastectomy and reconstruction after total mastectomy groups had similar quality of life. Efforts to evaluate and improve the quality of life of patients with breast cancer should be continued.

show abstract

Reliability of the Beck Depression Inventory with older adults.

Cited by 217 publications

References 2 publications

Nicotine treatment of mild cognitive impairment

Nicotine treatment of mild cognitive impairment

Changes in Participation Level after Spouse’s First Stroke and Relationship to Burden and Depressive Symptoms

Comparison of Quality of Life Based on Surgical Technique in Patients with Breast Cancer

Contact Info

Product

Resources

About